Main > > >LEFT ATRIAL APPENDAGE (LAA).

---

Cardio.>Arrhytmia. Atrial Fibrillation
(AFi). NonValvular AF
(NVAF). Stroke/Systemic Embolism Risk
Reduction:
Left Atrial Appendage (LAA) Closure De-
vice. (U>Ab.)
EU Approval Date: 2013. 01.18.
(*) Company; Patents & TradeMark Avai-
lable on Request
UpDate: 2019. 03.03.




Cardio.>Arrhytmia. Atrial Fibrillation
(AFi). NonValvular AF
(NVAF). Stroke/Systemic Embolism Risk
Reduction:
Left Atrial Appendage (LAA) Closure De-
vice. (U>Bo.)
EU Approval Date : 2009.
USA Approval Date: 2015. 03.13.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 03.04.




Cardio.>Left Atrial Appendage (LAA) Closure Device. (U>At.)
In Arrhytmia>Atrial Fibrillation (AFi.)
Patients.
EU >Approved.
JP >Approved.
USA>Launched.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 03.17.




Cardio.>Left Atrial Appendage (LAA) Closure Device. (U>Ab.)
Stroke Risk Reduction in NonValvular
AFi Patients.
EU Approval Date: 2013. 01.18.
(*) Company; Patents & TradeMark Avai-
lable on Request.
UpDate: 2019. 03.03.




Cardio.>Left Atrial Appendage (LAA) Closure Device. (U>Bo.)
Stroke Risk Reduction in NonValvular
AFi Patients.
EU Approval Date : 2009.
USA Approval Date: 2015. 03.13.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 03.04.


>LEFT ATRIAL APPENDAGE (LAA).'s products
This section has no products